Optimizing Transitions of Care in Pulmonary Arterial Hypertension: Importance of a Multidisciplinary Approach


This educational activity is supported by independent medical educational grants from Bayer Healthcare Pharmaceuticals Inc. and Actelion Pharmaceuticals Inc
 

This activity is jointly provided by Global Education Group and Physicians’ Education Resource®, LLC.

On Demand Webinar

Faculty

Amy L. Dzierba, PharmD, FCCM, FCCP, BCCCP
Clinical Pharmacy Manager, Adult Critical Care
NewYork-Presbyterian Hospital
Columbia University Irving Medical Center
New York, New York
 
Amy Kimber, RN, APNP
Nurse Practitioner
Pulmonary and Critical Care Medicine
Froedtert and the Medical College of Wisconsin
Milwaukee, Wisconsin
 
Irene Swift, MD
Christiana Care Health System
Department of Pulmonary Medicine
Medical Director, Pulmonary Hypertension Program
Newark, Delaware

Activity Overview

Pulmonary arterial hypertension (PAH) is a chronic disease affecting the pulmonary vasculature. Proper evaluation and diagnosing of PAH is vital to successful and efficient treatment. Guidelines from the European Society of Cardiology and European Respiratory Society provide recommendations to healthcare providers to ensure proper treatment of PAH patients; however, proper communication and effective transitions of care between healthcare providers and facilities remains an essential area for improvement. In this webinar, a panel of expert faculty will review guideline recommendations for evaluating, diagnosis, and treating the PAH patient. Additionally, it will touch briefly on pharmacologic and nonpharmacologic therapies. Furthermore, it will highlight barriers to effective transitions of care programs in addition to strategies and methodologies to overcoming those barriers. Lastly, it will discuss both individual and team based roles that various healthcare providers play with respect to optimal treatment of the PAH patient.

Educational Objectives

At the completion of this activity, the participant will be able to:
  • EXPLAIN the guideline-based procedures for diagnosing PAH
  • RECOGNIZE when to refer patients to expert care centers when PAH is suspected.
  • RESTATE recently published, evidence-based PAH treatment guidelines for incorporation into care transition activities including medications and medication reconciliation, prevention of drug interaction, management of comorbidities, and patient education.
  • EXPLAIN how to implement safe and effective transitions of care strategies to improve treatment outcomes for patients with PAH while considering individual patient needs
  • DESCRIBE key roles of inter-professional team members in carrying out effective transitions of care for patients with PAH
 
Targeted Audience: This educational activity is directed toward primary care and specialty nurse practitioners involved in the treatment and management of patients with PAH. Cardiologists, pulmonologists, primary care providers, nurses, physician assistants, case managers and other healthcare professionals interested in the treatment of PAH may also participate.
 
Length of Webinar: 1 hour
Release Date: March 30, 2018
Expiration Date: March 30, 2019
Fee: Free
 
Nurse Practitioner Continuing Education
AANP Provider Logo - Updated 01-22-2013This activity has been planned and implemented in accordance with the accreditation Standards of the American Association of Nurse Practitioners (AANP) through joint providership of Global Education Group and Physicians’ Education Resource®, LLC. Global Education Group is accredited by the American Association of Nurse Practitioners as an approved provider of nurse practitioner continuing education.  Provider number: 1561024. This activity is approved for 1.0 contact hour, which includes 0 hour(s) of pharmacology.
Activity ID 2606E
This activity was planned in accordance with AANP CE Standards and Policies.
 

Global Contact Information

For information about the accreditation of this program, please contact Global at 303-395-1782 or cme@globaleducationgroup.com.

Instructions to Receive Credit

To receive credit, participants must complete the online pretest, view the activity in its entirety, and complete the online posttest and activity evaluation form. After completing the online assessment tests, and completing the activity evaluation form, participants may request credit. All participants must request credit by March 30, 2019; CE credit will not be issued after this date.

Disclosure of Conflicts of Interest

Global Education Group (Global) requires instructors, planners, managers and other individuals and their spouse/life partner who are in a position to control the content of this activity to disclose any real or apparent conflict of interest they may have as related to the content of this activity. All identified conflicts of interest are thoroughly vetted by Global for fair balance, scientific objectivity of studies mentioned in the materials or used as the basis for content, and appropriateness of patient care recommendations.
 
The faculty reported the following financial relationships or relationships to products or devices they or their spouse/life partner have with commercial interests related to the content of this CME activity:
 
Name of Faculty or Presenter Reported Financial Relationship
Arny L. Dzierba, PharrnD, FCCM, FCCP, BCCCP Nothing to disclose
Amy Kimber, RN, APNP, ANP-BC Advisory Board: Actelion, Bayer
Irene Swift, MD Nothing to disclose
 
The planners and managers reported the following financial relationships or relationships to products or devices they or their spouse/life partner have with commercial interests related to the content of this CME activity:
Name of Planner or Manager Reported Financial Relationship
Kristen Delisi, NP Nothing to disclose
Lindsay Borvansky Nothing to disclose
Andrea Funk Nothing to disclose
Liddy Knight Nothing to disclose
David Heckard Nothing to disclose
Gloria Lauria Nothing to disclose
Katie Pierson Nothing to disclose


Disclosure of Unlabeled Use

This educational activity may contain discussion of published and/or investigational uses of agents that are not indicated by the FDA. Global Education Group (Global) and Physicians’ Education Resource®, LLC (PER) do not recommend the use of any agent outside of the labeled indications. 
The opinions expressed in the educational activity are those of the faculty and do not necessarily represent the views of any organization associated with this activity. Please refer to the official prescribing information for each product for discussion of approved indications, contraindications, and warnings.

Disclaimer

Participants have an implied responsibility to use the newly acquired information to enhance patient outcomes and their own professional development. The information presented in this activity is not meant to serve as a guideline for patient management. Any procedures, medications, or other courses of diagnosis or treatment discussed in this activity should not be used by clinicians without evaluation of patient conditions and possible contraindications on dangers in use, review of any applicable manufacturer’s product information, and comparison with recommendations of other authorities.

System Requirements

PC
Microsoft Windows 2000 SE or above.
Flash Player Plugin (v7.0.1.9 or greater)
Internet Explorer (v5.5 or greater), or Firefox
Adobe Acrobat Reader*
MAC OS 10.2.8
Flash Player Plugin (v7.0.1.9 or greater)
Safari
Adobe Acrobat Reader*
Internet Explorer is not supported on the Macintosh
 
For questions about this Internet CE activity, please contact: ceinfo@permedical.com
Privacy Policy and Terms of Use Information: http://www.gotoper.com/privacy






Become a Member

Forgot Password?
Filter By